#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Cortical dysplasia Optic glioma Scedosporium infection Oropharyngeal cancer recurrent Granulomatosis with polyangiitis Philadelphia positive acute lymphocytic leukaemia Acute lymphocytic leukaemia Haemophilia Hairy cell leukaemia Lymphatic malformation IgA nephropathy Mastocytosis Hereditary optic atrophy Pulmonary hypertension More trials…

    Learn about Rare Diseases

    Angelman’s syndrome – Life with Disease Toxic epidermal necrolysis – Treatment Mantle cell lymphoma stage IV – Treatment Retinitis pigmentosa Mantle cell lymphoma – Diagnostics Loeys-Dietz syndrome – Diagnostics Hairy cell leukaemia – Diagnostics Waldenstrom’s macroglobulinaemia – Diagnostics Mucopolysaccharidosis – Treatment Pemphigoid – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lazertinib RUBIDIUM CHLORIDE Ubiquinol Mexiletine Surzebiclimab ULIXERTINIB Meldonium Diphenhydramine Hydrochloride Caspofungin Resatorvid ADMILPARANT Cldn6 Rna-Lpx Metoclopramide Hydrochloride Atezolizumab Mirikizumab Mps-103 Edg-5506 Amiloride Hydrochloride ANERATRIGINE MESILATE Minocycline More therapies…

    Learn about Your Condition

    Ewing's sarcoma Myxoid liposarcoma Alagille syndrome Angiosarcoma metastatic Lung adenocarcinoma stage III Postpartum haemorrhage Herpes simplex meningitis Gastrointestinal melanoma Ventricular extrasystoles Foot deformity Mast cell activation syndrome Papilloma viral infection Friedreich's ataxia ROHHAD syndrome Cervix carcinoma stage I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Avalglucosidase Alfa
    Denmark

  • Study on Ticagrelor and Aspirin for Patients with Severe Aortic Stenosis After Heart Valve Replacement

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Ticagrelor
    Italy Portugal Spain

  • Study on Crohn’s Disease: Evaluating Risankizumab’s Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms

    Recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Belgium Bulgaria Czechia France Germany Italy +4

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Atomoxetine
    • Citalopram
    • Desvenlafaxine Benzoate
    Austria Germany Greece Italy Spain

  • Study on Esketamine for Treating Chronic Pain in Endometriosis Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Ondansetron
    • Sodium Chloride
    The Netherlands

  • Study of Nipocalimab in Pregnant Women at Risk of Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

    Recruiting

    3 1
    Investigated Diseases:
    • ABO haemolytic disease of newborn
    Investigated Drugs:
    • Nipocalimab
    Austria Belgium Czechia France Germany Ireland +5
Previous Page
1 … 565 566 567 568 569 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!